Business Context and Reporting Period
OptimumBank Holdings, Inc. filed this Form 8-K on January 13, 2011, reporting an event that occurred on January 10, 2011. The filing addresses a regulatory compliance issue regarding the company's listing status on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing compliance rather than financial performance.
Material Changes
The material change reported is the resignation of Jack Calloway from the Company's board of directors on January 6, 2011. This resignation reduced the number of independent directors to three out of six, causing the Company to fail compliance with Nasdaq Listing Rule 5605(b)(1), which requires a majority of independent directors.
Outlook, Risks, and Contingencies
- Delisting Risk: The Company faces potential delisting of its common stock if it cannot demonstrate compliance with the independent director requirement by the specified deadline.
- Cure Period: The Company has been granted a cure period ending on the earlier of its next annual shareholders' meeting or January 6, 2012. If the next annual meeting is held before July 5, 2011, the deadline is July 5, 2011.
- Management Action: The Company is actively seeking a qualified independent director to fill the vacancy.
- Appeal Process: If compliance is not met, the Company may appeal a delisting determination to a Listing Qualifications panel.
Investor Verification Checklist
- Verify the current composition of the Board of Directors and the status of the search for a new independent director.
- Confirm the date of the next annual shareholders' meeting to determine the exact compliance deadline.
- Monitor future filings for confirmation of a new director appointment or any further notices from Nasdaq regarding delisting.